LIMINATUS PHARMA INC. (LIMNW): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in LIMNW. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
3
13F filers
Aggregate Value
$24K
Across holders
Last Price
$0.05
2026-08-21
Sector
—
GICS
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. CIK 0001510281 | Hedge Fund | 234K | $12K | 49.2% | 0.0% | Unchanged | +$0 | Q2 2026 |
| MOORE CAPITAL MANAGEMENT, LP CIK 0001448574 | Hedge Fund | 125K | $9K | 38.7% | 0.0% | Unchanged | +$0 | Q2 2026 |
| SHAW D E & CO INC CIK 0001009207 | Hedge Fund | 83K | $3K | 12.1% | 0.0% | Unchanged | +$0 | Q2 2026 |
Loading recent insider activity…